# pathway_0155

[All questions](../README.md) · [Summary](../SUMMARY.md) · [Method](../METHOD.md) · [Exact reviewer input](../inputs/pathway_0155.txt)

**Task:** `pathway`  
**Expected answer:** **B** — Antifungal biosynthesis. .

| Reviewer | Expected-answer support | Reasoning versus lookup |
|---|---|---|
| GPT-6 Luna | supported | reasoning-supported |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported |

The reviewers assess the question and its expected answer. Their agreement is not expert confirmation. An unusable review is an output failure, not a finding that the question is wrong.

## Complete original question

```text
[Protein Sequence]
MSLQPTATEVGTMYDQYTSLLTDVMAGFIHVGYWDDPEREDTIEVATERLTREIGERLSSVRGQRILDVGCGTGKSAVQIATAHDVHITGITVSNHQIELAQSQYESNTKAGQVNFLFANAMDLPFADASFDGAYAIESLVHMDDRRTALTNIARVLRPGSRLAIADLFLDAGCPNPEVLARFHELFQVPPMPSGDDLKALLHQTGFKVIEFTDIRDTSGLSANF

[Multiple Choices]
A. L-fucose degradation. .
B. Antifungal biosynthesis. .
C. chorismate biosynthesis
D. L-homoserine from L-aspartate: step 2/3. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Reviewer assessments

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment.

Citations as saved: [C5](#evidence-c5).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The sequence-based family inference and the listed pathway chemistries favor B over the alternatives.


### Important caveats

- A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C5"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment."
  },
  "important_caveats": [
    "A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-based family inference and the listed pathway chemistries favor B over the alternatives."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt pathway annotation identifies antifungal biosynthesis and cites experimental evidence (ECO:0000269). This supports the keyed pathway, though the excerpt does not independently describe the underlying experiment.",
    "evidence_ids": ["C5"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a glycine-rich motif consistent with SAM binding in a small methyltransferase. A methyltransferase is a plausible tailoring enzyme in specialized antifungal biosynthesis, whereas the other choices describe pathways whose named steps are not methyl-transfer reactions. This provides a meaningful, probabilistic basis for choosing B among these options.",
    "missing_item_specific_fact": "",
    "reason": "The pathway is not uniquely determined by the motif alone, but transferable knowledge about SAM-dependent methyltransferases and pathway chemistry distinguishes B from the offered alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The sequence-based family inference and the listed pathway chemistries favor B over the alternatives."
  },
  "important_caveats": [
    "A SAM-binding methyltransferase motif does not by itself establish the enzyme's exact substrate or pathway."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination.


### Important caveats

- The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.
- 'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.
- The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.
- The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation."
  },
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported."
  },
  "important_caveats": [
    "The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.",
    "'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.",
    "The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.",
    "The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0155",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A0L1JF88, RSTN1_ASPN3) explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (inferred from direct assay, PubMed:33857369). The protein is an O-methyltransferase in the restricticin biosynthesis gene cluster; restricticin is a natural-product CYP51 inhibitor with antifungal activity. The annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains the motif 'VGCGTGKSAV' (GxGxxG pattern), a well-known Rossmann-fold signature characteristic of class I methyltransferases. This is standard transferable biochemistry knowledge. Applying this to the four choices: (A) L-fucose degradation involves fucose isomerase, fucokinase, and fuculose-1-phosphate aldolase — none are Rossmann-fold methyltransferases. (C) Chorismate biosynthesis involves DAHP synthase, DHQ synthase, shikimate dehydrogenase, shikimate kinase, EPSP synthase, and chorismate synthase — none are methyltransferases. (D) L-homoserine from L-aspartate step 2/3 is homoserine dehydrogenase, which IS a Rossmann-fold NAD(P)-dependent dehydrogenase, but it is typically ≥350–400 amino acids and contains additional regulatory domains; the 225-aa size and the specific motif context (GCGTGKSA rather than the catalytic Ser/Thr position-2 variant typical of dehydrogenases) are more consistent with a standalone methyltransferase. By elimination of A, C, and D on enzyme-family grounds, B ('Antifungal biosynthesis') remains as the only option compatible with a small fungal methyltransferase involved in secondary-metabolite tailoring. This is a legitimate family-level inference from transferable knowledge of enzyme folds and pathway enzyme inventories.",
    "missing_item_specific_fact": "",
    "reason": "The GxGxxG Rossmann-fold motif is a widely taught sequence signature. Knowing which enzyme types populate each listed pathway (isomerases/kinases/aldolases for fucose; synthases/dehydrogenases/kinases for chorismate; a large dehydrogenase for homoserine) allows elimination of A, C, and D. The 225-aa size further disfavors homoserine dehydrogenase. The remaining option B is broad enough to encompass a fungal methyltransferase in a natural-product biosynthetic cluster. The inference relies on general enzyme-family and pathway knowledge, not on recalling this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three distractors (A, C, D) name specific pathways whose constituent enzymes are well-characterized and structurally distinct from a small Rossmann-fold methyltransferase. 'Antifungal biosynthesis' (B) is a broad UniProt pathway category that encompasses tailoring enzymes including methyltransferases in fungal secondary-metabolite clusters, making it the only compatible choice after elimination."
  },
  "important_caveats": [
    "The GxGxxG motif identifies a Rossmann fold but does not uniquely prove methyltransferase activity from sequence alone; the inference also relies on protein size and motif context.",
    "'Antifungal biosynthesis' is a UniProt-specific pathway vocabulary term; a model unfamiliar with this exact nomenclature might find option B unusual, though elimination of A/C/D still points to it.",
    "The reviewer-only evidence confirms the annotation is experimentally supported (ECO:0000269), but this information was not available to the evaluated model.",
    "The argument that homoserine dehydrogenase is too large (≥350 aa) for a 225-aa protein is a reasonable size-based exclusion but is not an absolute proof; some truncated or engineered variants exist."
  ]
}
```

</details>

## Complete reviewer-only evidence and qualifications

These source excerpts were available to the reviewers. They were not included in the original benchmark-solving input.

**Source applicability:**

```json
{
  "actual_author_source_snapshot": "unknown",
  "benchmark_sequence_length": 225,
  "benchmark_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "current_entry_audit": {
    "entryVersion": 25,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2015-11-11",
    "sequenceVersion": 1
  },
  "current_record_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "current_sequence_comparison": "matched",
  "current_source_sequence_length": 225,
  "current_source_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "current_status": "retrieved",
  "current_uniprot_release": "2026_03",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 23,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "historical_status": "retrieved",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "latest_at_cutoff_sequence_comparison": "matched",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed.",
  "requested_accession": "A0A0L1JF88",
  "selected_historical_entry_version": 23,
  "selected_historical_record_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "selected_historical_source_sequence_length": 225,
  "selected_historical_source_sequence_sha256": "c81f547e718f545a528716fcbb0efd66301f895b7a6e7743da00b44566669860",
  "selected_historical_version": {
    "accession": "A0A0L1JF88",
    "database": "Swiss-Prot",
    "entryVersion": 23,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RSTN1_ASPN3",
    "sequenceVersion": 1
  }
}
```

**Qualifications:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C1",
  "excerpt": "\"A0A0L1JF88\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/primaryAccession",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C2",
  "excerpt": "{\"entryVersion\":25,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2015-11-11\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/entryAudit",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C3",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 / M93)\",\"taxonId\":1509407}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/organism",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C4",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein 1\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"O-methyltransferase rstn1\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/proteinDescription",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33857369\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/comments/3",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json)

```json
{
  "evidence_id": "C6",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu N.\",\"Abramyan E.D.\",\"Cheng W.\",\"Perlatti B.\",\"Harvey C.J.B.\",\"Bills G.F.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33857369\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.1c01516\"}],\"citationType\":\"journal article\",\"firstPage\":\"6043\",\"id\":\"33857369\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"6047\",\"publicationDate\":\"2021\",\"title\":\"Targeted genome mining reveals the biosynthetic gene clusters of natural product CYP51 inhibitors.\",\"volume\":\"143\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/1",
  "retrieved_utc": "2026-11-02T04:24:15.624587+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "dda8c813658a8c709826544ad5ddbd2ae972d7bfe23bb0ae87e41d05627a6d20",
  "url": "https://rest.uniprot.org/uniprotkb/A0A0L1JF88.json"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "entry_version": 23,
  "evidence_id": "H1",
  "excerpt": "ID   RSTN1_ASPN3             Reviewed;         225 AA.\nAC   A0A0L1JF88;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   11-NOV-2015, sequence version 1.\nDT   28-JAN-2026, entry version 23.\nDE   RecName: Full=O-methyltransferase rstn1 {ECO:0000303|PubMed:33857369};\nDE            EC=2.1.1.- {ECO:0000269|PubMed:33857369};\nDE   AltName: Full=Restricticin biosynthesis cluster protein 1 {ECO:0000303|PubMed:33857369};\nGN   Name=rstn1 {ECO:0000303|PubMed:33857369}; ORFNames=ANOM_001442;\nOS   Aspergillus nomiae NRRL (strain ATCC 15546 / NRRL 13137 / CBS 260.88 /\nOS   M93).\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=1509407;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 1-15",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "entry_version": 23,
  "evidence_id": "H2",
  "excerpt": "RN   [2]\nRP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.\nRX   PubMed=33857369; DOI=10.1021/jacs.1c01516;\nRA   Liu N., Abramyan E.D., Cheng W., Perlatti B., Harvey C.J.B., Bills G.F.,\nRA   Tang Y.;\nRT   \"Targeted genome mining reveals the biosynthetic gene clusters of natural\nRT   product CYP51 inhibitors.\";\nRL   J. Am. Chem. Soc. 143:6043-6047(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 24-31",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23)

```json
{
  "entry_version": 23,
  "evidence_id": "H3",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:33857369}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:24:17.437797+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 60-60",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "79e66fc3e8c4ef26bf02567903ff65dcc83c5c855359b04ab315caa7a97c6612",
  "url": "https://rest.uniprot.org/unisave/A0A0L1JF88?format=txt&versions=23"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 155. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
